Abeona Therapeutics Inc (NASDAQ: ABEO). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell on very heavy volume, and negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, ABEO is expected to be a major Value Builder.
Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Abeona Therapeutics has a very low Appreciation Score of 6 but a very high Power Rating of 89, with the Low Neutral Value Trend Rating the result.
Recent Price Action
Abeona Therapeutics Inc (NASDAQ: ABEO) stock closed at $3.17 on 4/24/24 after a large decline of -7.0%. Moreover, exceptionally high trading volume at 430% of normal accompanied the decline. The stock has declined -59.1% during the last week but has been exceptionally strong relative to the market over the last nine months.
Be the first to comment